An article in the New Scientist caught my eye this morning. It announced that EEG technology and AI have been combined to create a non-invasive thought-to-text device. The initial 40% accuracy rate is already increasing to 60% in the latest studies – so this has great potential – despite the ground still to be covered.

I have been an avid follower of developments in Brain-To-Machine (BMI) interfaces since 2012, when an AKQA project for Deutsche Telekom introduced me to Harvard Braingate, and the visionary worlds of Ray Kurzweil and Aubrey de Gray.

I was deeply excited by the AlterEgo experiments at MIT in 2018, but since then progress seemed to have stalled. However with the advent of generative AI, I was confident that progress would accelerate rapidly, as generative AI is an accelerant for almost everything.

During the course of 2023, I have speculated a few times with ChatGPT on what the development path for BMI consumer-grade devices might look like. So prompted by today’s article, we had another session to revisit our assumptions and predictions.

Here is the result of our collaboration. I am super excited for what the next 12 months might bring to the game-changing world of BMI technology!

We started by comparing the relative advantages of EEG and sub-vocalisation techniques, since they work in really different ways. Then we explored a combination of the two techniques in one device – and speculated about likely time-to-market and key use cases for the first consumer-grade device.

Advantages of a Hybrid BMI:

Potential Use Cases:

Path to market:

Predicting the first form of Brain-to-Machine Interface (BMI) device to hit the market involves considering several factors, including current technological advancements, market readiness, user acceptability, and regulatory approvals. Based on these considerations, here are a few hypotheses – and a prediction for how the technology and product landscape might evolve.

Hypotheses for Market Readiness:

Prediction: Given these hypotheses, it’s likely that an EEG-based device could be the first to hit the market. These devices have been around for a while, have a relatively established body of research, and can be designed to be non-invasive, which is a significant advantage in terms of user acceptability and regulatory approval.

As for the timeline, considering the current pace of technological advancements and the increasing interest in BMI technologies:

It’s important to note that these predictions are based on current trends and could be influenced by breakthroughs in technology, changes in market dynamics, or regulatory shifts. The field of BMI is rapidly evolving, and unexpected advancements could accelerate the timeline.